Macrolane for Enhancement of the Shape and Fullness of the Female Breast
NCT ID: NCT01308853
Last Updated: 2022-09-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2007-02-28
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Macrolane VRF30 for Enhancement of Shape and Fullness of Female Breast
NCT01299532
Macrolane Retrospective Study
NCT01223963
Macrolane Prospective Survey
NCT01223066
Treatment of Pectus Excavatum Deformity Using Macrolane Filler
NCT01750112
Evaluation of the Ulthera System for the Treatment of the Decolletage
NCT01713686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Macrolane
Open label
Macrolane
Device: Macrolane Treatment: Initial injection (incl touch-up) of a maximum of 120 ml/breast.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Macrolane
Device: Macrolane Treatment: Initial injection (incl touch-up) of a maximum of 120 ml/breast.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Any medical condition that may interfere with the treatment
25 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per Heden, M.D.
Role: PRINCIPAL_INVESTIGATOR
Akademikliniken, Stockholm, Sweden
References
Explore related publications, articles, or registry entries linked to this study.
Heden P, Olenius M, Tengvar M. Macrolane for breast enhancement: 12-month follow-up. Plast Reconstr Surg. 2011 Feb;127(2):850-860. doi: 10.1097/PRS.0b013e318200ae57.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31GB0607
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.